Mamounas, E. P., Tang, G., Paik, S., Baehner, F. L., Liu, Q., Jeong, J., . . . Wolmark, N. (2017). 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: Results from NSABP B-28/NRG Oncology. Breast Cancer Res Treat.
Citação norma ChicagoMamounas, Eleftherios P., et al. "21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy Plus Endocrine Therapy: Results From NSABP B-28/NRG Oncology." Breast Cancer Res Treat 2017.
Deismireacht MLAMamounas, Eleftherios P., et al. "21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy Plus Endocrine Therapy: Results From NSABP B-28/NRG Oncology." Breast Cancer Res Treat 2017.